Lee Fairlie to Raltegravir Potassium
This is a "connection" page, showing publications Lee Fairlie has written about Raltegravir Potassium.
Connection Strength
0,045
-
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):201-204.
Score: 0,045